Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Pulmonology, Critical Care and Sleep Medicine department at The Mount Sinai Hospital is ranked No. 17 in the nation by U.S. News & World Report, 2022-23.
Through our affiliation with National Jewish Health—another leading respiratory hospital in the country—we have established the Mount Sinai-National Jewish Health Respiratory Institute to provide comprehensive patient care and conduct research that has a real and lasting effect on our patients today, and into the future. Our intensivists have been on the front lines of the COVID-19 pandemic, and have pioneered a number of innovative therapeutic techniques and medications that have saved countless lives.
Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Pulmonology, Critical Care and Sleep Medicine department at The Mount Sinai Hospital is ranked No. 17 in the nation by U.S. News & World Report, 2022-23.
Through our affiliation with National Jewish Health—another leading respiratory hospital in the country—we have established the Mount Sinai-National Jewish Health Respiratory Institute to provide comprehensive patient care and conduct research that has a real and lasting effect on our patients today, and into the future. Our intensivists have been on the front lines of the COVID-19 pandemic, and have pioneered a number of innovative therapeutic techniques and medications that have saved countless lives.
Mount Sinai's exercise physiology program, which went dormant during the COVID-19 pandemic, has been revitalized with a new leader, sleek state-of-the-art hardware, software upgrades, and more.
Mount Sinai's medical intensive care unit is adjusting to the "new normal" post-pandemic by ensuring that its teams have the tools to manage future crises.
Mount Sinai has launched a novel technology-driven teaching scholars curriculum that uses a blended learning model to prepare subspecialty pulmonary and critical care fellows for careers as clinician-educators.
Mount Sinai is undertaking several initiatives to better understand the factors that contribute to severe asthma and identify different subtypes of the disease. The work is intended to bring a precision medicine approach to asthma.
A Mount Sinai physician has developed an algorithm that uses a range of electronic medical record data to identify patients who are ready to be liberated from ventilation.
The Mount Sinai – National Jewish Health Respiratory Institute’s Pleural Service, launched in 2020, has used pleuroscopy to dramatically increase its reach and the number and acuity of patients it can serve.
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
This study provides one of the most comprehensive analyses of interstitial lung disease diagnosis and treatment in patients who received an antibody drug conjugate known as T-DXd, from a class of drugs designed as a targeted therapy for treating cancers.
Mount Sinai Health System, Jefferson Health, and National Jewish Health have begun working together to advance understanding, diagnosis, and treatment of a range of pulmonary diseases, some of which have traditionally been orphan diseases.
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, like the entire Mount Sinai Health System, is making concerted efforts to become an anti-racist institution.
The multidisciplinary Chronic Lung Care Program at Mount Sinai Kravis Children’s Hospital was established to help care for infants in the NICU with evolving and established chronic respiratory failure.
Gene signatures derived from lung carcinoma could potentially predict outcomes among individuals with small lung cancers detected by chest CT imaging, when those tumors cannot be distinguished visually as aggressive or indolent.
Fewer than 10 percent of potentially eligible patients undergo lung cancer screening, resulting in unnecessary illness and death. The new Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Morningside wants to change that.
Mount Sinai will serve as a hub site for two cohort studies as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, which will assess the post-acute sequelae of SARS-CoV-2 infection (PASC).
Mount Sinai Health System has recruited two world-renowned experts to establish a lung transplantation program that will care for both traditional and highly complex cases. The demand for these services is projected to grow as more patients ...
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Like-minded scientists and physician-scientists will collaborate with pulmonologists, otolaryngologists, head and neck oncologists, and transplant surgeons to collaborate on research related to the airway within the Institute for Airway ...
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Charles Powell, MD, System Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine and CEO of the Mount Sinai-National Jewish Health Respiratory Institute, answers questions regarding anti-HER2 monoclonal ...
Even before the first patient arrived at our doors, a Mount Sinai research team working with CT scans from patients in China noticed that this disease did not look like a normal pneumonia.
